HK1109576A1 - Aequorin-containing compositions and methods of using same - Google Patents
Aequorin-containing compositions and methods of using sameInfo
- Publication number
- HK1109576A1 HK1109576A1 HK08100338.3A HK08100338A HK1109576A1 HK 1109576 A1 HK1109576 A1 HK 1109576A1 HK 08100338 A HK08100338 A HK 08100338A HK 1109576 A1 HK1109576 A1 HK 1109576A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- aequorin
- methods
- same
- containing compositions
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/872,795 US20060229243A1 (en) | 2004-06-21 | 2004-06-21 | Aequorin-containing compositions and methods of using same |
PCT/US2005/021770 WO2006010004A2 (en) | 2004-06-21 | 2005-06-21 | Aequorin-containing compositions and methods of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1109576A1 true HK1109576A1 (en) | 2008-06-13 |
Family
ID=35785748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08100338.3A HK1109576A1 (en) | 2004-06-21 | 2008-01-10 | Aequorin-containing compositions and methods of using same |
Country Status (21)
Country | Link |
---|---|
US (3) | US20060229243A1 (ja) |
EP (2) | EP1768691B1 (ja) |
JP (1) | JP4971150B2 (ja) |
KR (1) | KR101213555B1 (ja) |
CN (1) | CN1997383B (ja) |
AU (1) | AU2005265266B2 (ja) |
BR (1) | BRPI0512392B1 (ja) |
CA (1) | CA2571542C (ja) |
CY (1) | CY1114307T1 (ja) |
DK (1) | DK1768691T3 (ja) |
ES (1) | ES2422173T3 (ja) |
HK (1) | HK1109576A1 (ja) |
IL (1) | IL180195A (ja) |
MX (1) | MXPA06015037A (ja) |
NZ (1) | NZ552274A (ja) |
PL (1) | PL1768691T3 (ja) |
PT (1) | PT1768691E (ja) |
SG (1) | SG153848A1 (ja) |
SI (1) | SI1768691T1 (ja) |
WO (1) | WO2006010004A2 (ja) |
ZA (1) | ZA200610688B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
GB0625678D0 (en) | 2006-12-21 | 2007-01-31 | Lux Biotechnology Ltd | Composition and method for detection of demineralisation |
WO2009114597A1 (en) * | 2008-03-11 | 2009-09-17 | Quincy Bioscience, Llc | Apoaequorin-containing compositions and methods of using same |
JP2010143860A (ja) * | 2008-12-19 | 2010-07-01 | Chisso Corp | タンパク質の安定化剤 |
US20110130336A1 (en) * | 2009-10-16 | 2011-06-02 | Quincy Bioscience, Llc | Method of treating ischemic injury using apoaequorin |
US9316588B2 (en) * | 2010-12-24 | 2016-04-19 | Otsuka Pharmaceutical Co., Ltd. | Bioassay method for detecting physiologically active substance |
MX350259B (es) * | 2011-11-15 | 2017-08-31 | Quincy Bioscience Llc | Apoaequorina para reducir daño neuronal debido a isquemia. |
GB201700317D0 (en) | 2017-01-09 | 2017-02-22 | Calcivis Ltd | Detection device |
USD1042180S1 (en) | 2020-05-28 | 2024-09-17 | Calcivis Limited | Dental detection device |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240855A (ja) * | 2000-03-01 | 2001-09-04 | Masashi Sugimoto | 生物発光方法及び発光物品 |
US6800492B2 (en) * | 2000-06-01 | 2004-10-05 | Institute Pasteur | Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
US6930169B2 (en) * | 2000-06-12 | 2005-08-16 | University Of Baltimore Biotechnology Institute | Method of controlling the binding of calmyrin to presenilin |
US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
-
2004
- 2004-06-21 US US10/872,795 patent/US20060229243A1/en not_active Abandoned
-
2005
- 2005-06-21 US US11/571,043 patent/US7671015B2/en active Active
- 2005-06-21 SI SI200531724T patent/SI1768691T1/sl unknown
- 2005-06-21 DK DK05766584.6T patent/DK1768691T3/da active
- 2005-06-21 PL PL05766584T patent/PL1768691T3/pl unknown
- 2005-06-21 AU AU2005265266A patent/AU2005265266B2/en active Active
- 2005-06-21 MX MXPA06015037A patent/MXPA06015037A/es active IP Right Grant
- 2005-06-21 CA CA2571542A patent/CA2571542C/en active Active
- 2005-06-21 WO PCT/US2005/021770 patent/WO2006010004A2/en active Application Filing
- 2005-06-21 EP EP05766584.6A patent/EP1768691B1/en active Active
- 2005-06-21 JP JP2007518179A patent/JP4971150B2/ja active Active
- 2005-06-21 NZ NZ552274A patent/NZ552274A/en unknown
- 2005-06-21 SG SG200904273-0A patent/SG153848A1/en unknown
- 2005-06-21 BR BRPI0512392-5A patent/BRPI0512392B1/pt active IP Right Grant
- 2005-06-21 PT PT57665846T patent/PT1768691E/pt unknown
- 2005-06-21 KR KR1020077001461A patent/KR101213555B1/ko active IP Right Grant
- 2005-06-21 CN CN200580024585XA patent/CN1997383B/zh active Active
- 2005-06-21 ES ES05766584T patent/ES2422173T3/es active Active
- 2005-06-21 EP EP12188025.6A patent/EP2545934B1/en not_active Not-in-force
-
2006
- 2006-12-19 ZA ZA200610688A patent/ZA200610688B/en unknown
- 2006-12-19 IL IL180195A patent/IL180195A/en active IP Right Grant
-
2008
- 2008-01-10 HK HK08100338.3A patent/HK1109576A1/xx unknown
-
2010
- 2010-01-27 US US12/694,427 patent/US20100152117A1/en not_active Abandoned
-
2013
- 2013-06-14 CY CY20131100486T patent/CY1114307T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20182133T1 (hr) | Pripravci koji sadrže azelastin i postupci njihove upotrebe | |
IL181543A0 (en) | Dendrimer based compositions and methods of using the same | |
EP1735456A4 (en) | POYLMERIC COMPOSITIONS AND ASSOCIATED METHODS OF USE | |
EP1827464A4 (en) | ZINC COMPOSITIONS AND METHODS OF USE | |
IL180907A0 (en) | Risedronate compositions and their methods of use | |
IL219406A0 (en) | Antiloading compositions and methods of selecting same | |
IL182943A0 (en) | Ovr110 antibody compositions and methods of use | |
EP1786265A4 (en) | NEW COMPOSITIONS AND PROCESSING METHODS | |
EP1763358A4 (en) | COMPOSITIONS AND METHODS CUT-HUNGER | |
ZA200606545B (en) | Chronotherapeutic compositions and methods of their use | |
HK1109576A1 (en) | Aequorin-containing compositions and methods of using same | |
IL184062A0 (en) | Visco-supplement composition and methods | |
EP1769007A4 (en) | POLYMER COMPOSITIONS AND METHODS OF USE THEREOF | |
GB0520930D0 (en) | Composition and method of use | |
EP1625141A4 (en) | GRP94-BASED COMPOSITIONS AND METHODS OF USE THEREOF | |
IL179962A0 (en) | Compositions and methods of use of dimer digallates | |
ZA200706038B (en) | Visco-supplement composition and methods | |
GB0428034D0 (en) | Compositions and methods | |
GB0517168D0 (en) | Composition and method of use | |
AU2005904981A0 (en) | Compositions and methods of using same | |
AU2005904711A0 (en) | Compositions and methods of use thereof | |
GB0419260D0 (en) | Skincare compositions and methods | |
AU2004900511A0 (en) | Compositions and Methods of Treatment | |
AU2004904405A0 (en) | Compositions and Methods of Treatment |